Profile data is unavailable for this security.
About the company
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
- Revenue in USD (TTM)2.28m
- Net income in USD-34.59m
- Incorporated2016
- Employees13.00
- LocationNutriband Inc121 S Orange Ave Ste 1500ORLANDO 32801-3241United StatesUSA
- Phone+1 (407) 377-6695
- Websitehttps://nutriband.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Icecure Medical Ltd | 2.98m | -15.29m | 39.31m | 64.00 | -- | 4.22 | -- | 13.21 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
| Cytosorbents Corp | 34.35m | -10.59m | 40.28m | 149.00 | -- | 4.47 | -- | 1.17 | -0.19 | -0.19 | 0.56 | 0.1436 | 0.7344 | 2.18 | 4.89 | 230,553.30 | -22.63 | -34.58 | -28.22 | -41.80 | 77.02 | 70.00 | -30.81 | -62.08 | 1.71 | -- | 0.6176 | -- | 14.51 | 7.37 | 29.16 | -- | -15.13 | -- |
| Precipio Inc | 22.80m | -1.25m | 40.98m | 54.00 | -- | 2.97 | 169.34 | 1.80 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 41.01m | 18.00 | -- | 5.75 | -- | 3.39 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| electroCore, Inc. | 29.84m | -14.16m | 43.42m | 73.00 | -- | -- | -- | 1.46 | -1.70 | -1.70 | 3.59 | -0.1405 | 1.41 | 2.63 | 29.39 | 408,698.60 | -66.70 | -65.38 | -126.40 | -87.87 | 86.04 | 80.72 | -47.46 | -159.34 | 1.33 | -- | 1.20 | -- | 57.09 | 60.15 | 36.89 | -- | -- | -- |
| Heartbeam Inc | 0.00 | -20.62m | 45.81m | 16.00 | -- | 112.50 | -- | -- | -0.6638 | -0.6638 | 0.00 | 0.0118 | 0.00 | -- | -- | 0.00 | -432.60 | -142.55 | -792.01 | -190.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.85 | -- | -- | -- |
| Spectral AI Inc | 23.17m | -16.37m | 47.57m | 78.00 | -- | -- | -- | 2.05 | -0.7206 | -0.7206 | 0.9706 | -0.301 | 1.72 | 28.41 | 12.12 | 297,025.70 | -121.66 | -- | -- | -- | 45.01 | -- | -70.64 | -- | 0.8252 | -11.99 | -- | -- | 63.83 | -- | 26.56 | -- | -- | -- |
| Nutriband Inc | 2.28m | -34.59m | 50.04m | 13.00 | -- | 6.62 | -- | 21.96 | -3.07 | -3.07 | 0.2003 | 0.621 | 0.2174 | 9.96 | 17.72 | -- | -121.91 | -66.47 | -134.92 | -78.04 | 33.50 | 37.16 | -560.85 | -340.94 | 7.35 | -- | 0.022 | -- | 2.60 | 41.99 | -91.10 | -- | -- | -- |
| Sharps Technology Inc | 2.51m | -104.37m | 51.03m | 5.00 | -- | 0.1122 | -- | 20.32 | -690.20 | -690.20 | 0.3957 | 15.68 | 0.011 | 1.81 | -- | 502,354.00 | -45.86 | -86.10 | -47.44 | -125.43 | 0.1489 | -- | -4,155.30 | -- | 3.67 | -- | 0.0173 | -- | -- | -- | 5.54 | -- | 65.50 | -- |
| Neuraxis Inc | 3.36m | -8.37m | 52.31m | 21.00 | -- | 21.28 | -- | 15.56 | -1.02 | -1.02 | 0.4059 | 0.2311 | 0.9718 | 7.94 | 41.74 | 160,111.00 | -217.93 | -- | -1,360.57 | -- | 84.34 | -- | -224.24 | -- | 1.55 | -97.22 | 0.0789 | -- | 9.18 | -- | 42.21 | -- | -- | -- |
| Alpha Pro Tech Ltd | 59.10m | 3.68m | 53.77m | 130.00 | 15.20 | 0.8535 | 11.94 | 0.9099 | 0.3415 | 0.3415 | 5.46 | 6.08 | 0.803 | 1.64 | 10.62 | 454,584.60 | 5.00 | 13.85 | 5.23 | 14.58 | 38.21 | 40.64 | 6.23 | 12.78 | 7.70 | -- | 0.00 | 0.00 | -5.54 | 4.39 | -6.21 | 5.54 | 24.04 | -- |
| CS Diagnostics Corp | 0.00 | -341.62k | 57.50m | 5.00 | -- | -- | -- | -- | -531,454.00 | -531,454.00 | -- | -- | 0.00 | -- | -- | -- | -579.61 | -1,264.84 | -- | -- | -- | -- | -- | -209,220.50 | -- | -- | -- | -- | -- | -- | 32.83 | -- | -- | -- |
| Medinotec Inc | 11.43m | 2.34m | 58.78m | 51.00 | 25.08 | 10.69 | 24.69 | 5.14 | 0.1994 | 0.1994 | 0.9734 | 0.4679 | 1.87 | 4.04 | 7.03 | 224,166.50 | 38.33 | -- | 49.87 | -- | 58.25 | -- | 20.48 | -- | 3.89 | 37.94 | 0.00008 | -- | 81.53 | -- | 633.61 | -- | -- | -- |
| Pulmonx Corp | 91.66m | -56.75m | 60.63m | 291.00 | -- | 1.01 | -- | 0.6615 | -1.41 | -1.41 | 2.28 | 1.46 | 0.5997 | 1.47 | 7.20 | 314,996.60 | -37.13 | -26.27 | -42.91 | -28.96 | 73.30 | 72.91 | -61.91 | -89.48 | 4.15 | -- | 0.3821 | -- | 22.01 | 20.78 | 7.31 | -- | 14.98 | -- |
| Outset Medical Inc | 119.48m | -81.65m | 61.59m | 354.00 | -- | 0.4852 | -- | 0.5155 | -6.81 | -6.81 | 7.91 | 6.99 | 0.4423 | 1.36 | 3.74 | -- | -30.23 | -37.90 | -35.71 | -43.82 | 39.13 | 24.03 | -68.34 | -116.47 | 5.40 | -10.15 | 0.4312 | -- | 5.09 | 19.06 | 36.20 | -- | -- | -- |
| Accuray Inc | 436.97m | -35.62m | 62.07m | 990.00 | -- | 1.16 | -- | 0.142 | -0.2982 | -0.2982 | 3.89 | 0.4713 | 0.9434 | 2.10 | 5.90 | 441,382.80 | -7.69 | -1.60 | -13.56 | -2.72 | 27.83 | 35.04 | -8.15 | -1.75 | 0.7091 | -0.3832 | 0.7178 | -- | 2.68 | 3.67 | 89.77 | -- | 2.76 | -- |
Data as of Feb 13 2026. Currency figures normalised to Nutriband Inc's reporting currency: US Dollar USD
2.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 174.93k | 1.44% |
| Geode Capital Management LLCas of 31 Dec 2025 | 59.94k | 0.49% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 25.11k | 0.21% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 24.97k | 0.21% |
| Cetera Investment Advisers LLCas of 30 Sep 2025 | 18.90k | 0.16% |
| Cogent Private Wealth, Inc.as of 31 Dec 2025 | 16.01k | 0.13% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025 | 13.95k | 0.12% |
| Haven Private LLCas of 31 Dec 2025 | 11.43k | 0.09% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 8.11k | 0.07% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 3.50k | 0.03% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
